Journal
CHEMICAL BIOLOGY & DRUG DESIGN
Volume 80, Issue 4, Pages 500-515Publisher
WILEY
DOI: 10.1111/j.1747-0285.2012.01440.x
Keywords
inhibition assays; metallo-ss-lactamases; pyrrole; tetrahydropyrimidine-2-thione
Ask authors/readers for more resources
Metallo-beta-lactamases (MBLs), produced by an increasing number of bacterial pathogens, facilitate the hydrolysis of many commonly used beta-lactam antibiotics. There are no clinically useful antagonists against MBLs. Two sets of tetrahydropyrimidine-2-thione and pyrrole derivatives were synthesized and assayed for their inhibitory effects on the catalytic activity of the IMP-1 MBL from Pseudomonas aeruginosa and Klebsiella pneumoniae. Nine compounds tested (1a, 3b, 5c, 6b, 7a, 8a, 11c, 13a, and 16a) showed micromolar inhibition constants (Ki values range from similar to 2080 mu m). Compounds 1c, 2b, and 15a showed only weak inhibition. In silico docking was employed to investigate the binding mode of each enantiomer of the strongest inhibitor, 5c (Ki = 19 +/- 9 mu m), as well as 7a (Ki = 21 +/- 10 mu m), the strongest inhibitor of the pyrrole series, in the active site of IMP-1.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available